EUR/USD 1.14402
-0.203%
Gold 4302.17
-0.951%
Oil 92.578
1.028%
USD/JPY 157.742
0.243%
GBP/USD 1.33494
-0.128%
GBP/JPY 210.582
0.112%
Browse More
  • English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
Market news: Britain will provide more defensive military assistance to Saudi Arabia.Market news: Ukraine claims to have attacked Russias Kubyshev oil refinery.Saudi Arabia, Egypt, Türkiye, and Pakistan held a quadrilateral meeting in New York on September 22 local time.On September 22nd, RSM UK analyst Thomas Pugh stated that UK net public borrowing in August rose sharply compared to the same period last year, meaning the upcoming budget will be more challenging than anticipated by new Prime Minister Andy Burnham or Chancellor of the Exchequer John Healy when they took office months ago. A new round of tax increases seems inevitable in October. Cumulative borrowing so far this fiscal year has reached £77.3 billion, far exceeding the £69.2 billion previously predicted by the budget oversight body, the OBR. Given rising inflation and the potential for increased spending in the budget, borrowing is expected to continue to significantly exceed expectations. However, with UK government bond yields high, investors are closely watching every borrowing figure for clues about the governments seriousness regarding fiscal discipline.On September 22, Novo Nordisk CEO Mike Dustdale stated that the company must take more steps to rebuild investor confidence, given that its flagship drugs, such as Ozempic, will face patent expirations early in the next decade. Dustdale said, "What weve learned over the past few years is that over-promising and under-delivering quickly erode trust." Investors "want to know whats next." Novo Nordisks stock price fell on Monday as investors were disappointed by the lack of detail in its turnaround plan during the companys Capital Markets Day. Novo Nordisk is facing patent expirations for Ozempic and Wegovy in the US and Europe, a product portfolio that currently accounts for about three-quarters of its sales. Novo Nordisk has pledged to launch more than five blockbuster drugs by 2030 and achieve more than $23 billion in new sales by 2035. These goals are widely considered to be in line with investor expectations. BMO Capital Markets analysts stated that Novo Nordisk is still in a phase where it needs to prove itself with results. Investors need a clearer understanding of the companys next-generation drugs and their potential market acceptance in order to rebuild confidence.

WTI advances toward $75.00 as China-related demand optimism offsets recession fears

Daniel Rogers

Jan 09, 2023 11:55

244.png 

 

In the early hours of Monday, WTI steadily climbs near the intraday high of $74.70 as bullish emotion competes with economic slowdown worries. Despite this, the weaker US Dollar and a light schedule allow buyers of black gold to maintain control following Friday's mixed performance.

 

In spite of this, the risk profile remains elevated in light of China's reopening of its borders after a three-year closure. On the same line, Guo Shuqing, party secretary of the People's Bank of China, made his remarks (PBOC).

 

Reuters, transmitting China unlock news, claimed that "about 2 billion journeys are anticipated this season, roughly doubling the volume of previous year, and recovering to 70% of 2019 levels," citing a statement from the Chinese government.

 

On the other side, PBOC's Shuqing stated, "The world's second-largest economy is likely to recover rapidly due to the country's optimal Covid-19 response and the continued implementation of its economic policies."

 

The US Dollar Index (DXY) fell the most in three weeks the day before, down 0.20% intraday to 103.70 as of press time, as the US employment report failed to excite greenback purchasers and the US activity numbers stoked fears of an economic slowdown. It's worth mentioning that the previous day's disappointing US wage growth, ISM Services PMI, and Factory Orders weighed on Treasury bond yields and the DXY.

 

On a different page, reports regarding a delay in the restoration of the colonial pipeline and the Russia-Ukraine conflict appear to also benefit energy buyers. Traders fear additional rate hikes ahead of the release of the Consumer Price Index (CPI) for December from China and the United States on Wednesday and Thursday, respectively, which tests the positive momentum.

Suggestion